Iron Overload in Chronic Kidney Disease: Less Ferritin, More T2MRI

Overview

Journal Front Med (Lausanne)

Specialty General Medicine

Date 2022 Apr 7

PMID 35386917

Authors

Abdulqadir J Nashwan

Mohamed A Yassin

Mohamed Izham Mohamed Ibrahim

Hanan F Abdul Rahim

Mujahed Shraim

Affiliations

Soon will be listed here.

Abstract

To date, there is no consensus on the most reliable marker of iron status in patients with chronic kidney disease (CKD). Serum ferritin is used routinely, although it may be a misleading marker for iron overload. The success of T2 MRI in monitoring iron overload in patients with hemoglobinopathies can be beneficial to monitoring patients with CKD.

Citing Articles

Lessons from Beta-Thalassemia for Improving Iron Overload Monitoring and Management in Kidney Failure.

Nashwan A, Yassin M Cureus. 2025; 17(1):e77620.

PMID: 39963620 PMC: 11831958. DOI: 10.7759/cureus.77620.

Mapping a Decade of Research: Bibliometric Analysis of Iron Overload in Chronic Kidney Disease.

Nashwan A, Kunjavara J, Al-Mashdali A, Yassin M Cureus. 2025; 16(12):e75766.

PMID: 39816307 PMC: 11733245. DOI: 10.7759/cureus.75766.

The Roles of DMT1 in Inflammatory and Degenerative Diseases.

Liu H, Li M, Deng Y, Hou Y, Hou L, Zhang X Mol Neurobiol. 2025; .

PMID: 39775481 DOI: 10.1007/s12035-025-04687-x.

Prevalence of iron overload in patients with chronic kidney disease on peritoneal dialysis: A scoping review.

Nashwan A, Abuawwad M, Jaradat J, Ibraheem A, Yassin M, Taha M Health Sci Rep. 2024; 7(9):e2255.

PMID: 39253350 PMC: 11381317. DOI: 10.1002/hsr2.2255.

High ferritin is associated with liver and bone marrow iron accumulation: Effects of 1-year deferoxamine treatment in hemodialysis-associated iron overload.

Nunes L, Dos Reis L, Osorio R, Guapyassu H, Moyses R, Leao Filho H PLoS One. 2024; 19(8):e0306255.

PMID: 39121099 PMC: 11315289. DOI: 10.1371/journal.pone.0306255.

References

Ghoti H, Rachmilewitz E, Simon-Lopez R, Gaber R, Katzir Z, Konen E . Evidence for tissue iron overload in long-term hemodialysis patients and the impact of withdrawing parenteral iron. Eur J Haematol. 2012; 89(1):87-93. DOI: 10.1111/j.1600-0609.2012.01783.x. View

Labranche R, Gilbert G, Cerny M, Vu K, Soulieres D, Olivie D . Liver Iron Quantification with MR Imaging: A Primer for Radiologists. Radiographics. 2018; 38(2):392-412. DOI: 10.1148/rg.2018170079. View

Mobarra N, Shanaki M, Ehteram H, Nasiri H, Sahmani M, Saeidi M . A Review on Iron Chelators in Treatment of Iron Overload Syndromes. Int J Hematol Oncol Stem Cell Res. 2016; 10(4):239-247. PMC: 5139945. View

Yilmaz M, Solak Y, Covic A, Goldsmith D, Kanbay M . Renal anemia of inflammation: the name is self-explanatory. Blood Purif. 2011; 32(3):220-5. DOI: 10.1159/000328037. View

Locatelli F, Barany P, Covic A, de Francisco A, Del Vecchio L, Goldsmith D . Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement. Nephrol Dial Transplant. 2013; 28(6):1346-59. DOI: 10.1093/ndt/gft033. View

Wood J, Enriquez C, Ghugre N, Tyzka J, Carson S, Nelson M . MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood. 2005; 106(4):1460-5. PMC: 1895207. DOI: 10.1182/blood-2004-10-3982. View

Anderson L, Holden S, Davis B, Prescott E, Charrier C, Bunce N . Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2002; 22(23):2171-9. DOI: 10.1053/euhj.2001.2822. View

Kanbour I, Chandra P, Soliman A, De Sanctis V, Nashwan A, Abusamaan S . Severe Liver Iron Concentrations (LIC) in 24 Patients with β-Thalassemia Major: Correlations with Serum Ferritin, Liver Enzymes and Endocrine Complications. Mediterr J Hematol Infect Dis. 2018; 10(1):e2018062. PMC: 6223579. DOI: 10.4084/MJHID.2018.062. View

Hsu C, McCulloch C, Curhan G . Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol. 2002; 13(2):504-510. DOI: 10.1681/ASN.V132504. View

10.

Wood J . Guidelines for quantifying iron overload. Hematology Am Soc Hematol Educ Program. 2015; 2014(1):210-5. DOI: 10.1182/asheducation-2014.1.210. View

11.

Gaweda A, Ginzburg Y, Chait Y, Germain M, Aronoff G, Rachmilewitz E . Iron dosing in kidney disease: inconsistency of evidence and clinical practice. Nephrol Dial Transplant. 2014; 30(2):187-96. PMC: 4309189. DOI: 10.1093/ndt/gfu104. View

12.

Canavese C, Bergamo D, Ciccone G, Longo F, Fop F, Thea A . Validation of serum ferritin values by magnetic susceptometry in predicting iron overload in dialysis patients. Kidney Int. 2004; 65(3):1091-8. DOI: 10.1111/j.1523-1755.2004.00480.x. View

13.

Lv J, Zhang L . Prevalence and Disease Burden of Chronic Kidney Disease. Adv Exp Med Biol. 2019; 1165:3-15. DOI: 10.1007/978-981-13-8871-2_1. View

14.

Ali M, Okar L, Iqbal P, Yassin M . Iatrogenic Iron Overload in a Patient With Chronic Kidney Disease: Is There a Correlation Between Serum Ferritin and Liver Iron Concentration Determined by MRI T2*?. Cureus. 2020; 12(6):e8914. PMC: 7389957. DOI: 10.7759/cureus.8914. View

15.

Rostoker G, Griuncelli M, Loridon C, Couprie R, Benmaadi A, Bounhiol C . Hemodialysis-associated hemosiderosis in the era of erythropoiesis-stimulating agents: a MRI study. Am J Med. 2012; 125(10):991-999.e1. DOI: 10.1016/j.amjmed.2012.01.015. View

16.

Shizukuda Y, Rosing D . Iron overload and arrhythmias: Influence of confounding factors. J Arrhythm. 2019; 35(4):575-583. PMC: 6686354. DOI: 10.1002/joa3.12208. View

17.

Alustiza J, Castiella A, de Juan M, Emparanza J, Artetxe J, Uranga M . Iron overload in the liver diagnostic and quantification. Eur J Radiol. 2006; 61(3):499-506. DOI: 10.1016/j.ejrad.2006.11.012. View

18.

Holman R, Olynyk J, Kulkarni H, Ferrari P . Characterization of hepatic and cardiac iron deposition during standard treatment of anaemia in haemodialysis. Nephrology (Carlton). 2016; 22(2):114-117. DOI: 10.1111/nep.12735. View

19.

Carney E . The impact of chronic kidney disease on global health. Nat Rev Nephrol. 2020; 16(5):251. DOI: 10.1038/s41581-020-0268-7. View

20.

Walker Jr E, Walker S . Effects of iron overload on the immune system. Ann Clin Lab Sci. 2000; 30(4):354-65. View